Aaron E. Miller

12.8k total citations
18 papers, 656 citations indexed

About

Aaron E. Miller is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Aaron E. Miller has authored 18 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 4 papers in Neurology and 3 papers in Molecular Biology. Recurrent topics in Aaron E. Miller's work include Multiple Sclerosis Research Studies (10 papers), Viral Infections and Immunology Research (3 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Aaron E. Miller is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Viral Infections and Immunology Research (3 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Aaron E. Miller collaborates with scholars based in United States, Canada and Spain. Aaron E. Miller's co-authors include P. Andrew Neighbour, Fred Lublin, Barry R. Bloom, Arthur I. Grayzel, B. G. W. Arnason, Benjamin H. Eidelman, J. S. Burks, John N. Whitaker, Patricia K. Coyle and Miriam K. Aronson and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Aaron E. Miller

17 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron E. Miller United States 10 381 151 145 131 117 18 656
A. Nespolo Italy 14 279 0.7× 160 1.1× 96 0.7× 75 0.6× 73 0.6× 44 509
Caterina Veroni Italy 17 391 1.0× 334 2.2× 100 0.7× 193 1.5× 205 1.8× 24 994
Fumie Hayashi Japan 10 158 0.4× 213 1.4× 103 0.7× 197 1.5× 54 0.5× 24 674
Mariano Marrodán Argentina 14 276 0.7× 80 0.5× 171 1.2× 91 0.7× 53 0.5× 39 570
Z Lević Serbia 14 339 0.9× 71 0.5× 154 1.1× 96 0.7× 85 0.7× 42 576
Tobias Moser Austria 11 243 0.6× 184 1.2× 141 1.0× 94 0.7× 118 1.0× 33 544
Ann Dring United Kingdom 15 277 0.7× 113 0.7× 296 2.0× 351 2.7× 151 1.3× 17 865
A. Dufour Italy 13 194 0.5× 215 1.4× 82 0.6× 92 0.7× 113 1.0× 28 515
Simona Pontecorvo Italy 12 209 0.5× 54 0.4× 93 0.6× 89 0.7× 112 1.0× 25 461
Yinan Zhang United States 13 209 0.5× 131 0.9× 106 0.7× 113 0.9× 211 1.8× 29 629

Countries citing papers authored by Aaron E. Miller

Since Specialization
Citations

This map shows the geographic impact of Aaron E. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron E. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron E. Miller more than expected).

Fields of papers citing papers by Aaron E. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron E. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron E. Miller. The network helps show where Aaron E. Miller may publish in the future.

Co-authorship network of co-authors of Aaron E. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron E. Miller. A scholar is included among the top collaborators of Aaron E. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron E. Miller. Aaron E. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Miller, Aaron E.. (2025). Pricing policy in the context of technological interaction: a scenario approach. Omsk Scientific Bulletin Series Society History Modernity. 10(2). 166–174.
2.
Oh, Jiwon, Mark Freedman, Aaron E. Miller, et al.. (2017). Long-term Efficacy of Teriflunomide in Patients Recently Diagnosed With Relapsing Forms of MS (P6.339). Neurology. 88(16_supplement). 2 indexed citations
3.
Freedman, Mark S., Xavier Montalbán, Aaron E. Miller, et al.. (2016). Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis. Multiple Sclerosis and Related Disorders. 10. 204–212. 24 indexed citations
4.
5.
Vidaurre, Óscar G., Jeffery D. Haines, Ilana Katz Sand, et al.. (2014). Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain. 137(8). 2271–2286. 136 indexed citations
6.
Miller, Aaron E., et al.. (2013). Neuroimmunology. Oxford University Press eBooks. 1 indexed citations
7.
Miller, Aaron E., et al.. (2013). Hashimoto’s Encephalopathy. Oxford University Press eBooks. 2 indexed citations
8.
Khan, Omar, Aaron E. Miller, Carlo Tornatore, J. Theodore Phillips, & Christopher J. Barnes. (2012). Practice patterns of US neurologists in patients with SPMS and PPMS. Neurology Clinical Practice. 2(1). 58–66. 9 indexed citations
9.
Miller, Aaron E.. (2005). Glatiramer acetate in the treatment of multiple sclerosis. Neurologic Clinics. 23(1). 215–231. 2 indexed citations
10.
Miller, Aaron E. & Patricia K. Coyle. (2004). CLINICAL FEATURES OF MULTIPLE SCLEROSIS. CONTINUUM Lifelong Learning in Neurology. 10(6). 38–73. 8 indexed citations
11.
Tullman, Mark, Fred Lublin, & Aaron E. Miller. (2002). Immunotherapy of multiple sclerosis--current practice and future directions.. PubMed. 39(2). 273–85. 9 indexed citations
12.
Schwid, S. R., Andrew Goodman, Brian R. Apatoff, et al.. (2000). Are quantitative functional measures more sensitive to worsening MS than traditional measures?. Neurology. 55(12). 1901–1903. 29 indexed citations
13.
Miller, Aaron E., L. Morgante, Patricia K. Coyle, et al.. (1997). A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology. 48(2). 312–314. 98 indexed citations
14.
Lublin, Fred, John N. Whitaker, Benjamin H. Eidelman, et al.. (1996). Management of patients receiving interferon beta-1b for multiple sclerosis. Neurology. 46(1). 12–18. 125 indexed citations
15.
Neighbour, P. Andrew, Arthur I. Grayzel, & Aaron E. Miller. (1982). Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.. PubMed. 49(1). 11–21. 69 indexed citations
16.
Miller, Aaron E., et al.. (1981). Immunological studies in senile dementia of the alzheimer type: Evidence for enhanced suppressor cell activity. Annals of Neurology. 10(6). 506–510. 65 indexed citations
17.
Neighbour, P. Andrew, Aaron E. Miller, & Barry R. Bloom. (1981). Interferon responses of leukocytes in multiple sclerosis. Neurology. 31(5). 561–561. 73 indexed citations
18.
Miller, Aaron E.. (1980). 117 PREVENTION OF ADOPTIVE TRANSFER OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN LEWIS RATS BY IN VITRO SUPPRESSOR ACTIVITY. Journal of Neuropathology & Experimental Neurology. 39(3). 376–376. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Nespolo Breakdown of academic impact, for papers by Caterina Veroni Breakdown of academic impact, for papers by Fumie Hayashi Breakdown of academic impact, for papers by Mariano Marrodán Breakdown of academic impact, for papers by Z Lević Breakdown of academic impact, for papers by Tobias Moser Breakdown of academic impact, for papers by Ann Dring Breakdown of academic impact, for papers by A. Dufour Breakdown of academic impact, for papers by Simona Pontecorvo Breakdown of academic impact, for papers by Yinan Zhang
Rankless by CCL
2026